Hepatitis C viremia and serum lipid levels: A clue from an epidemiology study

Journal of Hepatology

Volumn 50, Issue 2, 2009, Pages 422-423

  Dai, Chia Yen ^a,b   Chuang, Wan Long ^a,b   Ho, Chi Kung ^a   Yu, Ming Lung ^a,b  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID; VIRUS RNA;

DISEASE SEVERITY; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HISTOPATHOLOGY; LETTER; LIPID BLOOD LEVEL; LIVER BIOPSY; LIVER CELL; LIVER CIRRHOSIS; PRIORITY JOURNAL; VIREMIA;

EID: 58149470369     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2008.11.002     Document Type: Letter

References (10)

1. Dai C.Y., Chuang W.L., Ho C.K., Hsieh M.Y., Huang J.F., Lee L.P., et al. Associations between hepatitis C viremia and low serum triglyceride and cholesterol levels: a community-based study. J Hepatol 49 (2008) 9-16
2. Chu C.M., and Liaw Y.F. Chronic hepatitis B virus infection acquired in childhood: special emphasis on prognostic and therapeutic implication of delayed HBeAg seroconversion. J Viral Hepat 14 (2007) 147-152
3. Chu C.M., Hung S.J., Lin J., Tai D.I., and Liaw Y.F. Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum levels of aminotransferases. Am J Med 116 (2004) 829-834
4. Chuang W.L., Dai C.Y., Chang W.Y., Lee L.P., Lin Z.Y., Chen S.C., et al. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy. Antivir Ther 10 (2005) 125-133
5. Huang H., Sun F., Owen D.M., Li W., Chen Y., Gale Jr. M., et al. Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins. Proc Natl Acad Sci USA 104 (2007) 5848-5853
6. Ye J. Reliance of host cholesterol metabolic pathways for the life cycle of hepatitis C virus. PLoS Pathog 3 (2007) e108
7. Molina S., Castet V., Fournier-Wirth C., Pichard-Garcia L., Avner R., Harats D., et al. The low-density lipoprotein receptor plays a role in the infection of primary human hepatocytes by hepatitis C virus. J Hepatol 46 (2007) 411-419
8. Agnello V., Abel G., Elfahal M., Knight G.B., and Zhang Q.X. Hepatitis C virus and other Flaviviridae viruses enter cells via low density lipoprotein receptor. Proc Natl Acad Sci USA 96 (1999) 12766-12771
9. Chandler C.E., Wilder D.E., Pettini J.L., Savoy Y.E., Petras S.F., Chang G., et al. An MTP inhibitor that lowers plasma cholesterol and triglycerides in experimental animals and in humans. J Lipid Res 44 (2003) 1887-1901
10. Bader T., Fazili J., Madhoun M., Aston C., Hughes D., Rizvi S., et al. Fluvastatin inhibits hepatitis C replication in humans. Am J Gastroenterol 103 (2008) 1383-1389